News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
152 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21212)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (2286)
August (1402)
Day
2 (21)
3 (134)
4 (182)
5 (180)
6 (174)
7 (76)
9 (47)
10 (146)
11 (152)
12 (93)
13 (140)
14 (57)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
2
3
4
5
6
7
9
10
11
12
13
14
Insights
Austria’s new growth fund could further bolster its dynamic biotech innovation economy
The national growth vehicle isn’t biotech‑dedicated, but channeling capital toward life sciences would amplify Austria’s strong research hubs, nondilutive funding landscape and reputation as a champion in science and technology.
August 11, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Funding
Epicrispr, Infinimmune snag combined $165M in VC cash
Epicrispr Biotechnologies is working on an epigenetic medicine for facioscapulohumeral muscular dystrophy, while Infinimmune will advance a pair of antibodies for atopic dermatitis.
August 11, 2026
·
2 min read
·
Tristan Manalac
Artificial Intelligence
After billions in deals, Insilico CEO promises: ‘You haven’t seen anything yet’
Insilico Medicine CEO Alex Zhavoronkov’s mad dash across the BIO International Convention in June attracted plenty of eyes. But the executive would prefer industry watchers gawk at the billions of dollars’ worth of deals his company has struck.
August 11, 2026
·
4 min read
·
Annalee Armstrong
Venture capital
Vaderis fuels up with $152M series B to test rare vascular disease in Phase 3
Vaderis is hoping that engasertib will become the first approved medicine for hereditary hemorrhagic telangiectasia, a rare condition that can cause spontaneous bleeding.
August 11, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
August 11, 2026
·
11 min read
Press Releases
Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping
August 11, 2026
·
10 min read
Press Releases
Exor and Philips Extend Long-term Relationship Agreement
August 11, 2026
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Collaboration with Cellin Technologies
August 11, 2026
·
5 min read
Press Releases
Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG
August 11, 2026
·
3 min read
Press Releases
Zomedica Announces “Fourth Friday at Four” Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation
August 11, 2026
·
8 min read
1 of 16
Next